Translation. Region: Russian Federal
Source: Moscow Government – Government of Moscow –
Pharmaceutical enterprises of the special economic zone (SEZ) Technopolis Moscow brought 37 new drugs to the market in 2024. Among them are drugs for the treatment of cancer, multiple sclerosis, chronic myelogenous leukemia and others. This was reported by the Deputy Mayor of Moscow for Transport and Industry Maxim Liksutov.
“The capital plays a key role in the development of the domestic pharmaceutical industry and strengthening the country’s medicinal sovereignty. On the instructions of Sergei Sobyanin, the city has created a set of effective tools to support the industry, which allows for the regular introduction of popular drugs to the market and an increase in production volumes. Today, eight resident enterprises produce vital drugs in the Technopolis Moscow special economic zone; during their operation, they have produced products worth over 74 billion rubles. In 2024, three companies from the capital’s SEZ brought 37 new drugs to the market for the treatment of socially significant diseases,” said Maxim Liksutov.
The production facilities of pharmaceutical enterprises are located at two sites: Alabushevo and Pechatniki. In addition, they are participants in the largest pharmaceutical cluster in the country.
“Offset contracts are concluded with pharmaceutical companies from the Moscow SEZ, under the terms of which the enterprises produce innovative drugs, and the city guarantees their purchase. The enterprises have high-tech production lines, modern laboratories, invest in research and development work. All this contributes to the creation of new effective drugs,” said the Minister of the Moscow Government, head of the capital’s Department of Investment and Industrial Policy
In March 2023, the Russian Ministry of Health registered the first Russian original drug for the treatment of multiple sclerosis, developed by scientists from the Russian biotechnology company Biocad and the Russian National Research Medical University named after N.I. Pirogov. The innovative drug reduces the immune-inflammatory process in the central nervous system, which reduces the number of exacerbations in patients with multiple sclerosis.
The resident of the SEZ Technopolis Moscow invested more than one billion rubles in the development and research of the drug. Production successfully began last year on the territory of the Alabushevo site. Since then, the enterprise has produced more than seven thousand packages of the product.
The company “R-Opra” (the group of companies “R-Pharm”) is also actively developing new types of drugs for the treatment of oncological, autoimmune, asthmatic and other diseases.
The project to create a modern pharmaceutical production complex at the capital’s SEZ site became possible thanks to an offset contract, said Gennady Degtyarev, General Director of the Technopolis Moscow special economic zone. In 2024, the resident opened a production site for the production of drugs in the form of soft gelatin capsules, which are used in the treatment of oncological diseases. In addition, last year the company mastered more than 10 new medicinal products for the treatment of socially significant diseases.
Another company, a resident of the Moscow SEZ, Amedart, opened import-substituting production of 26 new drugs at the Pechatniki site in 2024. Among them are, for example, drugs for the treatment of oncological diseases and the therapy of the human immunodeficiency virus (HIV). The start of production of these critically important drugs is a significant step in providing Russian patients with affordable and high-quality medicines.
New modern equipment allows the resident to annually produce up to 10 million packages of antiretroviral drugs for HIV therapy and up to one million packages of antitumor drugs. The company’s portfolio includes a total of more than 100 items included in the list of vital drugs. Their production capacity reaches 15 million packages per year.
Sobyanin opened the Kalashnikov concern complex in Technopolis MoscowSobyanin told what new industrial enterprises will open in Moscow
SEZ Technopolis Moscow is a territory with a special legal status, where a preferential regime of entrepreneurial activity for investors operates. The area of the facilities where high-tech enterprises are located exceeds 390 hectares. SEZ Technopolis Moscow has been a leader in international and national industry ratings for several years.
Get the latest news quickly official telegram channel the city of Moscow.
Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.
Please Note; This Information is Raw Content Directly from the Information Source. It is access to What the Source Is Stating and Does Not Reflect
https: //vv.mos.ru/nevs/ite/153087073/